Akerna Crecimiento futuro

Future controles de criterios 0/6

Actualmente no disponemos de suficiente cobertura de analistas para prever el crecimiento y los ingresos de Akerna.

Información clave

n/a

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Software	15.6%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera futura	n/a
Cobertura de analistas	None
Última actualización	n/a

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Akerna Corp.'s (NASDAQ:KERN) Revenues Are Not Doing Enough For Some Investors

Oct 19

Akerna announces $5M private placement of convertible redeemable preferred stock

Oct 03

Akerna Corp. (NASDAQ:KERN) Analysts Just Slashed This Year's Revenue Estimates By 12%

Aug 14

The Akerna (NASDAQ:KERN) Share Price Has Gained 14% And Shareholders Are Hoping For More

Mar 10

Here's What Akerna Corp.'s (NASDAQ:KERN) Shareholder Ownership Structure Looks Like

Feb 03

Integrate Akerna Into Your Cannabis Investment Basket

Feb 02

En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como Akerna no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.

Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.

Previsiones de crecimiento de beneficios e ingresos

NasdaqCM:KERN - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
9/30/2023	10	-21	-7	-6	N/A
6/30/2023	11	-24	-10	-8	N/A
3/31/2023	12	-41	-14	-10	N/A
12/31/2022	14	-60	-15	-11	N/A
9/30/2022	14	-64	-19	-14	N/A
6/30/2022	16	-60	-17	-12	N/A
3/31/2022	18	-46	-16	-10	N/A
12/31/2021	18	-31	-14	-8	N/A
9/30/2021	18	-26	-14	-10	N/A
6/30/2021	17	-29	-16	-12	N/A
3/31/2021	15	-28	-19	-15	N/A
12/31/2020	14	-26	-21	-17	N/A
9/30/2020	13	-18	-19	-15	N/A
6/30/2020	13	-14	-18	-14	N/A
3/31/2020	13	-18	-14	-14	N/A
12/31/2019	12	-15	-13	-12	N/A
9/30/2019	12	-13	-12	-11	N/A
6/30/2019	11	-12	-9	-9	N/A
3/31/2019	10	-7	-7	-7	N/A
12/31/2018	10	-4	-4	-4	N/A
9/30/2018	10	-3	-3	-3	N/A
6/30/2018	10	-2	-4	-4	N/A
6/30/2017	6	-7	N/A	-5	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de KERN es superior a la tasa de ahorro (2.3%).

Beneficios vs. Mercado: Datos insuficientes para determinar si se prevé que los beneficios de KERN crezcan más rápidamente que el mercado US

Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de KERN crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de KERN crezcan más rápidamente que el mercado de US.

Ingresos de alto crecimiento: No hay datos suficientes para determinar si se prevé que los ingresos de KERN crezcan a un ritmo superior a 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de KERN se prevé que sea elevada dentro de 3 años.

Descubre empresas en crecimiento

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Akerna Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Consensus revenue estimates fall by 44%

Consensus forecasts updated

Consensus forecasts updated

Consensus forecasts updated

Price target decreased to US$3.13

Consensus forecasts updated

Recent updates

Akerna Corp.(NasdaqCM:KERN) dropped from NASDAQ Composite Index

Akerna Announces Special Meeting to Vote on Gryphon Digital Merger

Akerna Corp., Annual General Meeting, Dec 28, 2023

Insufficient new directors

Akerna Corp. Announces Resignation of Barry Fishman as Director

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Akerna Corp.'s (NASDAQ:KERN) Revenues Are Not Doing Enough For Some Investors

Akerna Receives a Determination Letter from the Listing Qualifications Staff of the Nasdaq Stock Market

New major risk - Financial position

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Akerna Corp. announced that it expects to receive $0.5 million in funding from MJ Bridge Co., Inc.

First quarter 2023 earnings released: US$0.48 loss per share (vs US$13.89 loss in 1Q 2022)

Consensus revenue estimates fall by 44%

Full year 2022 earnings released: US$20.35 loss per share (vs US$24.44 loss in FY 2021)

Akerna Regains Compliance with NASDAQ Continued Listing Requirements

Gryphon Digital Mining, Inc. entered into an agreement to acquire Akerna Corp. (NasdaqCM:KERN) in a reverse merger transaction.

POSaBIT Systems Corporation agreed to a acquire MJ Platform, Leaf Data Systems LLC, and Ample Organics Inc. from Akerna Corp. for $4 million.

365 Holdco LLC acquired 365 Cannabis from Akerna Corp. (NasdaqCM:KERN) for $2.8 million.

Consensus forecasts updated

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Akerna Corp. Announces Intent to Effect Reverse Stock Split

Akerna Corp. announced that it has received $5 million in funding

Akerna Corp. announced that it expects to receive $5 million in funding

Akerna announces $5M private placement of convertible redeemable preferred stock

Akerna Corp. has completed a Follow-on Equity Offering in the amount of $23.1 million.

Akerna Corp. has completed a Follow-on Equity Offering in the amount of $23.1 million.

Consensus forecasts updated

Akerna Corp. (NASDAQ:KERN) Analysts Just Slashed This Year's Revenue Estimates By 12%

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Akerna Corp. Reports Impairment of Long-Lived Assets for the Second Quarter Ended June 30, 2022

Akerna GAAP EPS of -$0.83, revenue of $6.1M

Akerna Corp. to Report Q2, 2022 Results on Aug 10, 2022

High number of new directors

Akerna Corp. Appoints Larry Dean Ditto as Chief Financial Officer

Akerna Corp. has completed a Composite Units Offering in the amount of $9.99859 million.

Akerna Corp. has completed a Composite Units Offering in the amount of $9.99859 million.

Akerna slashes 48%, prices $10M offering

Akerna Corp., Annual General Meeting, May 25, 2022

Akerna Corp. Announces Management Changes

Consensus forecasts updated

Akerna Corp., Annual General Meeting, May 23, 2022

Akerna Corp. Reports Impairment of Long-Lived Assets for the First Quarter Ended March 31, 2022

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target decreased to US$3.13

High number of new and inexperienced directors

Akerna Corp., Annual General Meeting, May 13, 2022

Consensus forecasts updated

Price target decreased to US$6.83

Akerna Corp.: Pot Industry Enabler

Independent Director recently bought US$346k worth of stock

Akerna Corp. (NasdaqCM:KERN) signed an agreement to acquire 365 Cannabis for $25 million.

Is Akerna (NASDAQ:KERN) Using Debt In A Risky Way?

Consensus forecasts updated

Price target decreased to US$7.83

Akerna Corp.(NasdaqCM:KERN) dropped from Russell 3000E Index

Akerna Corp. announced delayed 10-Q filing

First quarter 2021 earnings released: US$0.28 loss per share (vs US$0.38 loss in 1Q 2020)

Is Akerna (NASDAQ:KERN) Using Debt Sensibly?

Second quarter 2021 earnings released: US$0.67 loss per share (vs US$0.40 loss in 2Q 2020)

Akerna Corp. Announces Impairment of Long-Lived Assets for the Second Quarter Ended December 31, 2020

Akerna Corp., Annual General Meeting, May 27, 2021

Akerna Corp. (NasdaqCM:KERN) signed an agreement to acquire Viridian Sciences for $ 6 million.

The Akerna (NASDAQ:KERN) Share Price Has Gained 14% And Shareholders Are Hoping For More

New 90-day high: US$7.09

Here's What Akerna Corp.'s (NASDAQ:KERN) Shareholder Ownership Structure Looks Like

Integrate Akerna Into Your Cannabis Investment Basket

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción